Deinard A S, Ogburn P
Am J Obstet Gynecol. 1981 Jun 1;140(3):240-5. doi: 10.1016/0002-9378(81)90267-2.
One hundred eighty-nine women who were immunized with Influenza A/New Jersey/8/76 virus vaccine (InfA/NJ) just prior to or during their pregnancy were compared with a control group of 517 pregnant women who did not receive the vaccine. This longitudinal, prospective study demonstrated no association between immunization with InfA/NJ and maternal, perinatal, or infant complications. No teratogenicity was demonstrated, and the two groups of infants did not differ in physical or neurological assessments at birth and at 8 weeks of life.
189名在怀孕前或怀孕期间接种了甲型流感/新泽西/8/76病毒疫苗（InfA/NJ）的女性与517名未接种该疫苗的孕妇对照组进行了比较。这项纵向前瞻性研究表明，接种InfA/NJ疫苗与母亲、围产期或婴儿并发症之间没有关联。未显示出致畸性，两组婴儿在出生时和出生8周时的身体或神经学评估中没有差异。
